Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study

Autor: Brunner, I, Hermine Quartier, Pierre Alexeeva, Ekaterina and Constantin, Tamas Kone-Paut, Isabelle Marzan, Katherine and Schneider, Rayfel Wulffraat, Nico M. Chasnyk, Vyacheslav and Tirosh, Irit Kallinich, Tilmann Kuemmerle-Deschner, Jasmin and Wouters, Carine Lauwerys, Bernard Nikishina, Irina Trachana, Maria Vougiouka, Olga Martini, Alberto Lovell, Daniel J. and Levy, Jeremy Vritzali, Eleni Ruperto, Nicolino Paediat Rheumatology Int Trials Or
Jazyk: angličtina
Rok vydání: 2020
Popis: Objective To evaluate the long-term efficacy and safety of canakinumab and explore prediction of response in patients with systemic juvenile idiopathic arthritis (JIA) with or without fever at treatment initiation. Methods At enrollment, patients with active systemic JIA (ages 2 to
Databáze: OpenAIRE